Calcium channels are involved in the hypnotic-anesthetic action of dexmedetomidine in rats

G. Horváth, M. Szikszay, G. Benedek

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Our study examined whether calcium channels are involved in the anesthetic action of dexmedetomidine (100-300 μg/kg), a highly selective α2-adrenoceptor agonist. To investigate this, we studied the effects of verapamil (1.25 or 2.5 mg/kg), a calcium channel blocker, and BAY K8644 (0.5 or 1 mg/kg), a calcium channel agonist, on the hypnotic-anesthetic effect of dexmedetomidine in rats. Loss of the righting reflex was used to determine the presence of anesthesia, and its length in minutes was referred to as the duration of hypnosis. Verapamil significantly enhanced the duration of the hypnotic-anesthetic action of dexmedetomidine (P <0.05). In contrast, BAY K8644 caused a significantly increased onset of hypnosis (P <0.001) and attenuated the anesthetic property of dexmedetomidine. These results suggest that the hypnotic-anesthetic action of dexmedetomidine is influenced by the activation/gating of calcium channels.

Original languageEnglish
Pages (from-to)884-888
Number of pages5
JournalAnesthesia and Analgesia
Volume74
Issue number6
Publication statusPublished - 1992

Fingerprint

Dexmedetomidine
Calcium Channels
Hypnotics and Sedatives
Anesthetics
Hypnosis
Verapamil
Calcium Channel Agonists
Righting Reflex
Calcium Channel Blockers
Adrenergic Receptors
Anesthesia

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Calcium channels are involved in the hypnotic-anesthetic action of dexmedetomidine in rats. / Horváth, G.; Szikszay, M.; Benedek, G.

In: Anesthesia and Analgesia, Vol. 74, No. 6, 1992, p. 884-888.

Research output: Contribution to journalArticle

@article{313e161ce26b42639ff5d2a30ca5f61e,
title = "Calcium channels are involved in the hypnotic-anesthetic action of dexmedetomidine in rats",
abstract = "Our study examined whether calcium channels are involved in the anesthetic action of dexmedetomidine (100-300 μg/kg), a highly selective α2-adrenoceptor agonist. To investigate this, we studied the effects of verapamil (1.25 or 2.5 mg/kg), a calcium channel blocker, and BAY K8644 (0.5 or 1 mg/kg), a calcium channel agonist, on the hypnotic-anesthetic effect of dexmedetomidine in rats. Loss of the righting reflex was used to determine the presence of anesthesia, and its length in minutes was referred to as the duration of hypnosis. Verapamil significantly enhanced the duration of the hypnotic-anesthetic action of dexmedetomidine (P <0.05). In contrast, BAY K8644 caused a significantly increased onset of hypnosis (P <0.001) and attenuated the anesthetic property of dexmedetomidine. These results suggest that the hypnotic-anesthetic action of dexmedetomidine is influenced by the activation/gating of calcium channels.",
author = "G. Horv{\'a}th and M. Szikszay and G. Benedek",
year = "1992",
language = "English",
volume = "74",
pages = "884--888",
journal = "Anesthesia and Analgesia",
issn = "0003-2999",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Calcium channels are involved in the hypnotic-anesthetic action of dexmedetomidine in rats

AU - Horváth, G.

AU - Szikszay, M.

AU - Benedek, G.

PY - 1992

Y1 - 1992

N2 - Our study examined whether calcium channels are involved in the anesthetic action of dexmedetomidine (100-300 μg/kg), a highly selective α2-adrenoceptor agonist. To investigate this, we studied the effects of verapamil (1.25 or 2.5 mg/kg), a calcium channel blocker, and BAY K8644 (0.5 or 1 mg/kg), a calcium channel agonist, on the hypnotic-anesthetic effect of dexmedetomidine in rats. Loss of the righting reflex was used to determine the presence of anesthesia, and its length in minutes was referred to as the duration of hypnosis. Verapamil significantly enhanced the duration of the hypnotic-anesthetic action of dexmedetomidine (P <0.05). In contrast, BAY K8644 caused a significantly increased onset of hypnosis (P <0.001) and attenuated the anesthetic property of dexmedetomidine. These results suggest that the hypnotic-anesthetic action of dexmedetomidine is influenced by the activation/gating of calcium channels.

AB - Our study examined whether calcium channels are involved in the anesthetic action of dexmedetomidine (100-300 μg/kg), a highly selective α2-adrenoceptor agonist. To investigate this, we studied the effects of verapamil (1.25 or 2.5 mg/kg), a calcium channel blocker, and BAY K8644 (0.5 or 1 mg/kg), a calcium channel agonist, on the hypnotic-anesthetic effect of dexmedetomidine in rats. Loss of the righting reflex was used to determine the presence of anesthesia, and its length in minutes was referred to as the duration of hypnosis. Verapamil significantly enhanced the duration of the hypnotic-anesthetic action of dexmedetomidine (P <0.05). In contrast, BAY K8644 caused a significantly increased onset of hypnosis (P <0.001) and attenuated the anesthetic property of dexmedetomidine. These results suggest that the hypnotic-anesthetic action of dexmedetomidine is influenced by the activation/gating of calcium channels.

UR - http://www.scopus.com/inward/record.url?scp=0026681883&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026681883&partnerID=8YFLogxK

M3 - Article

C2 - 1375817

AN - SCOPUS:0026681883

VL - 74

SP - 884

EP - 888

JO - Anesthesia and Analgesia

JF - Anesthesia and Analgesia

SN - 0003-2999

IS - 6

ER -